Back

TEER plus medical therapy vs medical therapy alone for symptomatic moderate-to-severe functional mitral regurgitation: a comprehensive, up-to-date meta-analysis of randomized trials

30 August 2025 (14:54 - 15:06)
Organised by: Logo
Congress Presentation Part of: Advances in mitral valve interventions Mitral Valve Intervention ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Nicola Ammirabile

AOU Policlinico - G. Rodolico San Marco, Catania (Italy)

3 More presentations in this session

Presentation thumbnail
Patient-specific simulation for optimizing transcatheter edge-to-edge repair strategies in mitral regurgitation
Doctor S. Feng (Beijing, CN)
Abstract Slides Video
Presentation thumbnail
Long-term clinical and hemodynamic outcomes of transcatheter mitral valve replacement
Doctor N. Groshenry (Paris, FR)
Abstract Slides Video
Presentation thumbnail
Post-procedural in-hospital, short and long-term outcomes of transcatheter (percutaneous) versus surgical approach for management of patients with non-rheumatic mitral valve stenosis.
Doctor A. Kostojchin (New York City, US)
Abstract Slides Video

Access the full session

Session thumbnail
Advances in mitral valve interventions
Video

The Event

Event poster

ESC Congress 2025

30 August 2025 14:54 CET
You may be interested in
thumbnail
Congress Session
Advances in mitral valve interventions
thumbnail
Congress Session
HOT LINE 3
thumbnail
Congress Session
Transcatheter mitral valve interventions: how to select the proper patients

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources